Wang Chang-Hua, Yu Ben-Xia, Zhou Hua-Rong, Liu Xiang, Zhang Zhi-Wei, Zhong Guo-Yue
Chongqing Academy of Chinese Materia Medica, Chongqing 400065, China.
Chongqing Sub-center of National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Science, Chongqing 400065, China.
Zhongguo Zhong Yao Za Zhi. 2016 Dec;41(24):4654-4662. doi: 10.4268/cjcmm20162427.
In this paper, the varieties and origin of Primulaceae plants that used in Tibetan medicine were analyzed. The results showed that there were 3 genera and 44 species (including the varieties) of Primulaceae plants were recorded in the relevant literatures. Among them, 17 varieties were recorded in Tibetan names, 24 varieties were recorded in Chinese names and 1 variety was used in both of them. In current quality criteria of standards at all levels in China country, 6 varieties were recorded in Tibetan names and 6 original plants were involved, which were 35% and 14% of them respectively. Seventeen varieties were recorded in Chinese name and 7 original plants were involved, which were 30% and 16% of them respectively. In Tibetan medicine standards and literatures, there were big differences between Tibetan names and Chinese names which were translated from Tibetan names and its original plants. There were only regulations of morphological identification and microscopic authentication, so the standards were very inadequate. Therefore, through literatures research, resources and current situation investigations, combining the research and specification of the name and original of Tibetan medicine, the level of normalization and standardization could be enhanced, the stable and controllable safety and utility in clinical medication could be ensured to promote advancement of industry technology Tibetan medicine.
本文对藏药中报春花科植物的种类及来源进行了分析。结果表明，相关文献记载的报春花科植物有3属44种（含变种）。其中，藏名记载17种，中文名记载24种，二者重复1种。在我国各级现行质量标准中，藏名记载6种，涉及基原植物6种，分别占其总数的35%和14%；中文名记载17种，涉及基原植物7种，分别占其总数的30%和16%。在藏药标准及文献中，藏名与由藏名翻译的中文名及其基原植物之间存在较大差异，且仅有形态鉴定和显微鉴别规范，标准很不完善。因此，通过文献研究、资源及现状调查，结合藏药名称及基原的研究与规范，可提高规范化、标准化水平，确保临床用药安全有效、稳定可控，促进藏药产业技术进步。
